RxDoctor Payments Data

Bret Fisher, MD

Ophthalmology · Homewood, ALNPI 1174559660

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $486,855 of the $545,478 with a category attached, or 89.3%. Ziemer USA accounts for 75.6% of it on its own, with 19 other manufacturers making up the rest. Among ophthalmology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$545,478in general payments, 2019–2025

Across 265 payments — averaging $2058.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ziemer USA$413K
  • Alcon$86K
  • Alcon Research LLC$33K
  • Ocular Therapeutix, Inc.$10K
  • Bausch & Lomb Americas Inc.$3K
  • Johnson & Johnson Surgical Vision, Inc.$512
  • plus $2K from 14 others
$280,617in research payments, 2019–2025

Across 204 payments — averaging $1375.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$275K
  • Sun Pharmaceutical Industries Inc.$6K

What the payments were for

  • Consulting fees$486,85589%
  • Speaking & faculty fees$39,1947%
  • Travel & lodging$11,5992%
  • Food & beverage$7,6901%
  • Other$1400%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$545,478 in reported general payments places this provider in the 95th percentile of 197 ophthalmology providers in Alabama.

See all ophthalmology providers in Alabama

Medicare billing

Part B allowed, 2024
$85,412
Medicare patients
138
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium324$5,253
Prednisolone Acetate64$3,356
Loteprednol Etabonate13$2,451
MoxifloxacinMoxifloxacin Hcl24$1,077
Latanoprost24$261

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Homewood

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →